PRDM2 and colorectal carcinoma: We have presented the first direct evidence for the role of c.4459delA as a driver mutation in CRC that affects global H3K9 dimethylation and that the inactivation of PRDM2 by C-terminal truncation is linked to increased tumorigenic potential.